相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
Wenjing Zhao et al.
BIOSCIENCE REPORTS (2012)
The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization
Adiel Barak et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2012)
Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye
Ulrich Schraermeyer et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys
Sylvie Julien et al.
NEUROBIOLOGY OF AGING (2012)
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
Christine Schmucker et al.
PLOS ONE (2012)
EFFECT OF INTRAVITREAL BEVACIZUMAB ON RETROBULBAR BLOOD FLOW IN INJECTED AND UNINJECTED FELLOW EYES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Hamid Hosseini et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Emerging Evidence Concerning Systemic Safety of Anti-VEGF Agents - Should Ophthalmologists Be Concerned?
Laurence S. Lim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Dynamics of a Heparin-Binding Domain of VEGF165 Complexed with Its Inhibitor Triamterene
Ki-Woong Jeong et al.
BIOCHEMISTRY (2011)
Toxicological considerations for intravitreal drugs
Fernando M. Penha et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes
Doan C. Nguyen et al.
IMMUNOGENETICS (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Arterial Thromboembolic Events in Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Bevacizumab or Ranibizumab
Angela M. Carneiro et al.
OPHTHALMOLOGICA (2011)
The Effect of Intravitreal Injection of Bevacizumab on Retinal Circulation in Patients with Neovascular Macular Degeneration
Olivier Fontaine et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Retinal artery occlusion following intravitreal anti-VEGF therapy
Therese von Hanno et al.
ACTA OPHTHALMOLOGICA (2010)
Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites
Michelle J. Boyle et al.
BLOOD (2010)
The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension
R. Rasier et al.
EYE (2009)
Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice
T. Meyer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther et al.
SURVEY OF OPHTHALMOLOGY (2009)
Effect of Intravitreal Injection of High-Dose Bevacizumab in Monkey Eyes
Kenji Sakurai et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
A new weapon for attacking tumor blood vessels
Gregg L. Semenza
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Electron opaque structures in human platelets: Which are or are not dense bodies?
James G. White
PLATELETS (2008)
Reversible Posterior Leukoencephalopathy Syndrome in Cancer
Christopher Vaughn et al.
CURRENT ONCOLOGY REPORTS (2008)
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
Frank A. Scappaticci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
Swaantje Peters et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Penetration of bevacizumab through the retina after intravitreal injection in the monkey
Peter Heiduschka et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: A single institutional survey
Vamsidhar Velcheti et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Choroidal neovascularization
HE Grossniklaus et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Heparan sulphate identified on human erythrocytes:: a Plasmodium falciparum receptor
AM Vogt et al.
BIOCHEMICAL JOURNAL (2004)
Soluble FcγRIIa inhibits rheumatoid factor binding to immune complexes
BD Wines et al.
IMMUNOLOGY (2003)
Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1α domain of PfEMP1
AM Vogt et al.
BLOOD (2003)
Fcγ receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro
AE Tebo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
分享论文
